This is a preview of subscription content, log in via an institution to check access.
Reference
van der Valk ME, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study. Gut : 7 Nov 2012. Available from: URL: http://dx.doi.org/10.1136/gutjnl-2012-303376
Additional information
* Costs Of Inflammatory bowel disease in the Netherlands
** 2011 values
Rights and permissions
About this article
Cite this article
Finding the COIN for IBD in the Netherlands. PharmacoEconomics & Outcomes News 668, 7 (2012). https://doi.org/10.1007/s40274-012-0022-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-012-0022-x